Table 1. Up-regulated pathways in recurrent stage II+IIIA triple negative breast cancer.
| Pathways | p-value |
|---|---|
| BDNF signaling pathway | 3.81E-10 |
| Integrated Breast Cancer Pathway | 4.07E-10 |
| EGF EGFR Signaling Pathway | 9.46E-10 |
| Cytoplasmic Ribosomal Proteins | 8.34E-09 |
| TSH signaling pathway | 1.04E-08 |
| Regulation of Actin Cytoskeleton | 1.75E-08 |
| Insulin Signaling | 7.48E-08 |
| Wnt Signaling Pathway | 1.78E-07 |
| Adipogenesis | 1.93E-07 |
| TGF beta Signaling Pathway | 2.43E-07 |
| Lymphocyte TarBase | 2.90E-07 |
| Prostate Cancer | 2.95E-07 |
| Androgen receptor signaling pathway | 4.69E-07 |
| Muscle cell TarBase | 4.72E-07 |
| Focal Adhesion | 6.92E-07 |
| Wnt Signaling Pathway and Pluripotency | 1.62E-06 |
| Integrated Pancreatic Cancer Pathway | 1.68E-06 |
| Neural Crest Differentiation | 1.95E-06 |
BDNF, brain-derived neurotrophic factor